Kevin Brian Cox - 01 Jul 2024 Form 4 Insider Report for SurgePays, Inc. (SURG)

Reporting relationship: CEO and Chairman of Board, Director
Issuer ticker: SURG
Reported as of: 01 Jul 2024
Net transaction value: -$63,826
SEC form: 4
Accepted by SEC: 03 Jul 2024, 16:09:20 UTC
Prior SEC filing: 04 Jun 2024
Next SEC filing: 05 Aug 2024
Source filing: View source filing
Reporting owner signature: /s/ Kevin Brian Cox

Key filing fact

Kevin Brian Cox filed Form 4 for SurgePays, Inc. (SURG) on 03 Jul 2024.

Key facts

This page summarizes Kevin Brian Cox's Form 4 filing for SurgePays, Inc. (SURG).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 03 Jul 2024, 16:09.

Change

Previous filing in this sequence was filed on 04 Jun 2024.
Current net transaction value: -$63,826.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SURG transaction

Restricted Shares (Common Stock)

Award

Transaction value: $0
Shares: +83,333
Change %: +1.5%
Price: $0.000000
Shares after: 5,708,961
Date: 01 Jul 2024
Ownership: Direct
Footnotes: F1, F2

SURG transaction

Shares of Common Stock)

Sale

Transaction value: $63,826
Shares: -20,915
Change %: -0.37%
Price: $3.05
Shares after: 5,688,046
Date: 02 Jul 2024
Ownership: Direct
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

Consists of an RSA grant in the amount of 83,333 set to vest on September 1, 2024.

Footnote F2

Includes (i) 83,334 RSAs that vested on July 1, 2024, and (ii) 83,334 RSAs that are set to vest on each of August 1, and September 1, 2024.

Footnote F3

The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

Footnote F4

Based upon shares sold at a high price of $3.11, a low price of $3.00, and an average of $3.0517. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.